News | September 18, 2007

Ischemic HF Patients Respond Better to PET-guided CRT Lead Placement

September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.

The preliminary study found that two-thirds of patients responded to therapy, despite evidence that CRT works only in patients with nonischemic heart failure, indicated Lucie Riedlbauchova, M.D., the Institute for Clinical and Experimental Medicine in Prague, Czech Republic.

"Our results show that CRT-associated reverse remodeling can be expected even in patients with extensive left ventricular scarring," said Dr. Riedlbauchova. "Using PET to place CRT leads remotely from the scar is associated with a more sizeable treatment effect."

The study involved 66 CRT patients with documented stenosis of 60 percent or more in at least one coronary artery (or a history of myocardial infarction), who received PET exams using both rubidium-82 perfusion imaging and 18F-FDG viability assessment prior to CRT implantation. The median follow-up was 16 months.
According to investigaors, lead placement and pacing remotely from scar area led to significant improvement in NYHA classification and to reverse remodeling. Myocardial hibernation or ischemia at the site of pacing did not affect the therapeutic impact of CRT.
The nonresponse rate was 35 percent, despite the presence of extensive left ventricular scarring in the patient population. Twenty patients died during follow-up, 14 of whom were nonresponders. Among the patients who died, the time from CRT implantation to death was significantly longer in patients who had responded to resynchronization therapy (34 months versus 9 months in nonresponders, P=0.01) and in patients who had scarring that involved less than 25 percent of the left ventricle (P=0.01 versus more extensive scarring).

For more information: www.asnc.org

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
Sponsored Content | Videos | Business| July 13, 2017
Randall Thompson, M.D., outlines three new CPT codes for FFR-CT, a smart phone-based single-lead ECG system and PET n
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging| July 07, 2017
Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
BioTrace Medical's Tempo Lead Shows Stability and Safety in Real-World Performance
News | Leads Implantable Devices| June 20, 2017
BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral presentation and...
cardiac nuclear myocardial perfusion imaging (MIP) exam guidelines for women
News | Nuclear Imaging| June 15, 2017
June 15, 2017 — The American Society of Nuclear Cardiology (ASNC) has published an updated consensus statement on evi
Overlay Init